Medical specialists from Canada tagged as investigators in clinical trials studying Leiomyosarcoma
Total 7 results
-
Abdulazeez SalawuSeen in:
- Ontario, Toronto, Princess Margaret Hospital
Trials:- NCT05269355 (Principal Investigator)
Conditions: -
Albiruni R. Abdul RazakSeen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:- NCT02923778 (Principal Investigator)
- NCT05836571 (Principal Investigator)
Conditions:- Soft Tissue Sarcoma;
- Leiomyosarcoma;
- Liposarcoma;
- Undifferentiated Pleomorphic Sarcoma;
- Soft Tissue Sarcoma of the Trunk and Extremities;
- Stage I Soft Tissue Sarcoma AJCC v7;
- Stage II Soft Tissue Sarcoma AJCC v7;
- Sarcoma G2;
- Sarcoma G3;
- Locally Advanced Leiomyosarcoma;
- Metastatic Undifferentiated Pleomorphic Sarcoma;
- Locally Advanced Liposarcoma;
- Locally Advanced Undifferentiated Pleomorphic Sarcoma;
- Locally Advanced Extraskeletal Myxoid Chondrosarcoma;
- Locally Advanced Unresectable Soft Tissue Sarcoma
-
Albiruni Razak, M.D.Seen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, UHN - Princess Margaret Cancer Center (Ontario)
- Toronto, Princess Margaret Cancer Center
Trials:- NCT03818412 (Principal Investigator)
- NCT04811196 (Principal Investigator)
- NCT05804045 (Principal Investigator)
- NCT05712694 (Principal Investigator)
-
Garth NicholasSeen in:
- Ontario, Ottawa, The Ottawa Hospital Cancer Centre
Trials:- NCT05269355 (Principal Investigator)
Conditions: -
Jonathan NoujaimSeen in:
- Quebec, Montreal, GSK Investigational Site
- Quebec, Montreal, Universite de Montreal - Hopital Maisonneuve-Rosemont (HMR)
Trials:- NCT04526509 (Principal Investigator)
- NCT05269355 (Principal Investigator)
- NCT03391778 (Principal Investigator)
Conditions: -
Ramy Saleh, MDSeen in:
- Quebec, Montréal, McGill University Health Centre (Quebec)
Trials:- NCT05712694 (Principal Investigator)
Conditions:
Clinical Trials on Leiomyosarcoma
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingLocally Advanced Leiomyosarcoma | Metastatic Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Leiomyosarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Leiomyosarcoma | Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IIIC Uterine Corpus Leiomyosarcoma... and other conditionsUnited States
-
National Cancer Institute (NCI)SuspendedLocally Advanced Uterine Corpus Leiomyosarcoma | Metastatic Uterine Corpus Leiomyosarcoma | Stage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Unresectable Uterine Corpus LeiomyosarcomaUnited States, Puerto Rico
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedUterus Leiomyosarcoma | Soft Tissue LeiomyosarcomaFrance
-
National Cancer Institute (NCI)Active, not recruitingStage III Uterine Corpus Leiomyosarcoma AJCC v8 | Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Uterine Corpus LeiomyosarcomaUnited States
-
Kristen GanjooRecruitingUterine Leiomyosarcoma | LMS - LeiomyosarcomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); EMD SeronoTerminatedMetastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Metastatic Liposarcoma | Unresectable LiposarcomaUnited States
-
David Liebner, MDWithdrawnLocally Advanced Leiomyosarcoma | Metastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Stage III Retroperitoneal Sarcoma AJCC v8 | Stage IIIA Retroperitoneal Sarcoma AJCC v8 | Stage IIIB Retroperitoneal Sarcoma AJCC v8 | Stage IV Retroperitoneal Sarcoma AJCC v8United States
-
Gachon University Gil Medical CenterMerck KGaA, Darmstadt, Germany; Chong Kun Dang Pharmaceutical Corp.RecruitingLeiomyosarcoma MetastaticKorea, Republic of